OPALEYE MANAGEMENT INC. – Celldex Therapeutics, Inc. Transaction History
OPALEYE MANAGEMENT INC. portfolio value:
$0
portfolio value
OPALEYE MANAGEMENT INC. quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -90K shares | -2.42M | $28.11 | 0 |
| Q2 2022 | share | Decrease | -53.96% | -105.5K shares | -4.23M | $26.96 | 90K |
| Q1 2022 | share | Decrease | -76.84% | -648.5K shares | -25.95M | $34.06 | 195.5K |
| Q4 2021 | share | Decrease | -14.31% | -141K shares | -20.43M | $38.9 | 844K |
| Q3 2021 | share | 0.00% | 0 shares | 20.10M | $53.99 | 985K | |
| Q2 2021 | share | 0.00% | 0 shares | 12.64M | $33.44 | 985K | |
| Q1 2021 | share | Decrease | -0.71% | -7K shares | 2.91M | $20.6 | 985K |
| Q4 2020 | share | 0.00% | 0 shares | 2.66M | $17.52 | 992K | |
| Q3 2020 | share | Decrease | -7.38% | -79K shares | 788K | $14.83 | 992K |
| Q2 2020 | share | Increase | 0.00% | 1.07M shares | 13.92M | $13 | 1.07M |